The National Times - EU massive fine against Google draws Trump threat

EU massive fine against Google draws Trump threat


EU massive fine against Google draws Trump threat

The EU on Friday slapped Google with a massive 2.95 billion euros ($3.47 billion) antitrust fine for favoring its own advertising services, drawing a furious rebuke from President Donald Trump and a threat of fresh tariffs against Europe.

Change text size:

Google vowed to appeal the decision by the European Commission, which accused the US firm of distorting competition in the 27-nation bloc.

"Google abused its dominant position in adtech, harming publishers, advertisers, and consumers. This behavior is illegal under EU antitrust rules," EU competition chief Teresa Ribera said.

Trump, who has threatened to go after Europe for its rules on the digital market and content policing, lashed out at the decision, which brings Google's total EU liabilities to nearly 10 billion euros.

"Very unfair, and the American taxpayer will not stand for it!" Trump said on his Truth Social network, a day after hosting top tech leaders including Google CEO Sundar Pichai at the White House.

"As I have said before, my Administration will NOT allow these discriminatory actions to stand," he added, warning that if the fine is confirmed, he will launch proceedings to impose tariffs as retaliation.

The dustup came as the EU is still waiting for the United States to make good on a promise to lower tariffs on cars under a trade deal agreed in July.

In its decision, Brussels ordered Google to end its "self-preferencing practices" and take steps to cease its inherent conflicts of interest.

"Google has 60 days to inform the Commission on how it plans to do so," Ribera said.

"If it fails to propose a viable plan, the Commission will not hesitate to impose an appropriate remedy."

She said that "at this stage, it appears that the only way for Google to end its conflict of interest effectively is with a structural remedy, such as selling some part of its adtech business."

Google said the commission's decision was wrong and it would appeal.

"It imposes an unjustified fine and requires changes that will hurt thousands of European businesses by making it harder for them to make money," said the firm's global head of regulatory affairs, Lee-Anne Mulholland.

Advertising is Google's financial bedrock. The firm's parent company Alphabet in July reported quarterly profits of $28.2 billion, largely from ads.

In its decision, the commission noted that Google not only sells advertising on its own websites and apps, but also acts as an intermediary for firms wanting to place ads elsewhere to appear on mobile and computer screens.

The European Publishers Council, a media industry group that had filed a complaint over the practices probed by the EU, said a fine was not enough.

"Without strong and decisive enforcement, Google will simply write this off as a cost of business while consolidating its dominance in the AI era," said its director Angela Mills Wade.

In a similar case, a US federal judge earlier this year decided against Google over its adtech practices. A trial to decide the remedies opens in Virginia on September 22.

Friday's announcement marked the third fine announced in a week against the Alphabet-owned Google.

A US federal jury on Wednesday ordered Google to pay about $425 million for gathering information from smartphone app users even when people opted for privacy settings.

The same day, France's data protection authority fined the search giant 325 million euros for failing to respect the law on internet cookies.

The group notched a major win, however, on Tuesday when a US judge rejected the American government's demand that Google sell its Chrome web browser.

The landmark antitrust ruling, coming after Google was found to have illegally maintained monopolies in online search through exclusive distribution agreements, did, however, impose sweeping data sharing requirements to restore competition.

As the EU's competition watchdog, the commission has hit Google with multiple fines in recent years.

It fined the online giant 4.1 billion euros in 2018 for abusing the market dominance of its Android operating system, and in 2017 slapped a 2.4 billion euos fine for anti-competitive practices in the price comparison market.

D.Cook--TNT

Featured

Carney touts Canada 'pivot' away from US as tariffs rise

Canadian Prime Minister Mark Carney on Tuesday said reducing economic ties with the United States would come at a cost but the long-term benefits were clear, as retaliatory tariffs on US products took effect.

The "Everlasting Battery" Inside Your Joints:UConn Professor's Self-Powered Healing Material just Got Acquired

A material that turns your own movement into medicine has just landed a corporate home. PetVivo Holdings (OTCQX: PETV), a veterinary biotech and biomedical device company focused on treating osteoarthritis in dogs and horses, has acquired PiezoBioMembrane (PBM) — a startup built around a biodegradable implant that generates electricity from the everyday force of a joint in motion, and uses that charge to help regrow cartilage from the inside out. The material is the invention of Thanh Nguyen, a professor of mechanical engineering in UConn's College of Engineering, who founded PBM in 2021 to advance new implementation methods for his work with piezoelectric materials — substances that convert mechanical force into electrical energy. These materials are typically ceramics: hard, brittle, and poorly suited for medical use. But Nguyen's lab developed new forms that are so , flexible, and biodegradable, breaking down naturally within the body over time. wound healing, The materials have already shown strong potential across a range of medical applications, including tissue regeneration, implanted force sensors, and targeted drug delivery in tumor treatment. How It Works biodegradable ultrasound for In the case of arthritis, Nguyen explains, the piezoelectric materials function as an off-the-shelf product that can be implanted or injected directly into the ailing joint — with no drugs, chemicals, or cells required. The everyday force exerted on the joint generates a small electrical charge, which helps regrow healthy cartilage, mimicking the body's natural use of electricity to regenerate tissue. "The body can be electrically stimulated to regrow," Nguyen says. PBM's materials "act like a battery — an everlasting battery that works whenever there is a force applied, and vanishes safely inside the body over time." PetVivo's Vision for the Acquisition PetVivo Holdings CEO John Lai expressed enthusiasm for the merger's potential to improve the lives of companion animals globally. "PBM has developed a compelling functional biomaterials platform with the potential to support the development of multiple medical device and therapeutic product lines across both human and animal health markets," Lai said in a press release. "By combining PBM's scientific innovation with PetVivo's product development capabilities, commercialization experience, regulatory expertise, and public company infrastructure, we believe we can accelerate theadvancement of technologies that may serve as the foundation for numerous future products and strategic opportunities." For Nguyen, the deal is a chance to scale technology that could eventually benefit both animals and people. "PetVivo is an animal health company, but they do have a big passion: pushing the technology towards clinical trials for human use," Nguyen says. "That aligned perfectly with my passion for developing technology that has an impact on human life. That is why I am excited about this merger, which facilitates my passion." A Track Record of Innovation Nguyen's research sits at the intersection of medicine, micro/nanotechnology, and biomaterials. His inventions have earned him publications in prominent scientific journals and media coverage from outlets including NPR. Nguyen founded PBM during the COVID-19 pandemic, a er realizing the material he had developed could be used to create an especially effective, biodegradable face mask — one where the mechanical force of breathing generated an electrical charge that provided an extra layer of protection against viruses. PBM is not Nguyen's only venture in the acquisition pipeline. His other startup, Single-Time Microneedles (STM), is also currently undergoing an acquisition process. STM has pioneered stable, efficient vaccine delivery technology in the form of an adhesive patch. shelfNguyen's focus on biodegradable materials has translated into a remarkably diverse range of medical applications. He has received five R01 grants from the National Institutes of Health (NIH) supporting research in cartilage regeneration, bone regeneration, HIV antibody delivery systems, and biodegradable ultrasound technology to boost the effectiveness of chemotherapy for brain cancer. "Whatever we are working on, we want to show that it works very well in vitro and in vivo," Nguyen says. "Then, when we are at the point of commercialization, we set up a startup or license the technology — or maybe team up with an industry partner." Thanh Nguyen is a professor of mechanical engineering in UConn's College of Engineering. (Courtesy of Thanh Nguyen

Octrado introduces its proprietary trading offering: "Your Skill. Our Capital"

Infrastructure, transparent rules and clear legal boundaries positioned as the core of the funded-account model

Could gas prices return to 2022 highs on US-Iran war?

European gas prices have more than doubled owing to the US-Iran war, just as Europe needs to replenish its reserves ahead of winter.

Change text size: